Charles Richardson
Chief Executive Officer bei KRS Biotechnology, Inc.
Profil
Charles E.
Richardson founded Cleveland Diabetes Care, Inc. in 2009, where he is working as Chief Executive Officer & Director from 2009.
Dr. Richardson also currently works at KRS Biotechnology, Inc., as Chief Executive Officer.
Dr. Richardson also formerly worked at Ribi ImmunoChem Research, Inc., as Vice President-Pharmaceutical Discovery, Corixa Corp., as Vice President-Manufacturing & Quality Assurance, LigoCyte Pharmaceuticals, Inc., as Executive Vice President-Research & Development from 2003 to 2015, Takeda Vaccines, Inc., as VP & Head-Global Chemistry & Manufacturing from 2012 to 2015, and Icosavax, Inc., as Senior Vice President-Technical Operations.
Dr. Richardson received his undergraduate degree from Carnegie Mellon University and doctorate degree from The University of Cincinnati College of Medicine.
Aktive Positionen von Charles Richardson
| Unternehmen | Position | Beginn |
|---|---|---|
KRS Biotechnology, Inc.
 KRS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology KRS Biotechnology, Inc. manufactures and supplies sterile compounded products. The company was founded inn 2001 and is headquartered in Boca Raton, FL. | Chief Executive Officer | - |
Cleveland Diabetes Care, Inc.
 Cleveland Diabetes Care, Inc. Pharmaceuticals: OtherHealth Technology Cleveland Diabetes Care, Inc. provides biopharmaceutical technology services. The company was founded by Charles Richardson in 2009 and is headquartered in Jacksonville, FL. | Founder | 01.01.2009 |
Ehemalige bekannte Positionen von Charles Richardson
| Unternehmen | Position | Ende |
|---|---|---|
| LigoCyte Pharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | 01.01.2015 |
Takeda Vaccines, Inc.
 Takeda Vaccines, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Vaccines, Inc. provides biological research and development services. The private company is based in Bozeman, MT. | Corporate Officer/Principal | 01.01.2015 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | 01.01.2003 |
| ICOSAVAX, INC. | Chief Tech/Sci/R&D Officer | - |
| Ribi ImmunoChem Research, Inc. | Corporate Officer/Principal | - |
Ausbildung von Charles Richardson
| Carnegie Mellon University | Undergraduate Degree |
| The University of Cincinnati College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
| Ribi ImmunoChem Research, Inc. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
| LigoCyte Pharmaceuticals, Inc. | Health Technology |
Takeda Vaccines, Inc.
Takeda Vaccines, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Vaccines, Inc. provides biological research and development services. The private company is based in Bozeman, MT. | Commercial Services |
KRS Biotechnology, Inc.
KRS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology KRS Biotechnology, Inc. manufactures and supplies sterile compounded products. The company was founded inn 2001 and is headquartered in Boca Raton, FL. | Health Technology |
Icosavax, Inc.
 Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
Cleveland Diabetes Care, Inc.
Cleveland Diabetes Care, Inc. Pharmaceuticals: OtherHealth Technology Cleveland Diabetes Care, Inc. provides biopharmaceutical technology services. The company was founded by Charles Richardson in 2009 and is headquartered in Jacksonville, FL. | Health Technology |
